— Cardinal Health (NYSE: CAH) reported second-quarter 2020 non-GAAP EPS attributable to the company of $1.52 vs. $1.22 expected.
— Revenue increased 5% to $39.7 billion vs. $39.43 billion expected.
— GAAP EPS attributable to the company decreased to $0.75 from $0.93 in the second quarter of 2019.
— For FY20, Cardinal Health lifted non-GAAP EPS attributable to the company outlook to a range of $5.20 to $5.40 from the previous range of $4.85 to $5.10.
— Pharmaceutical segment revenue increased 6% year-over-year to $35.7 billion.
— Medical segment revenue was flat with prior-year-quarter at $4 billion.
— CAH stock rose about 6% in the pre-market trading session.
Most Popular
AAPL Earnings: Apple’s Q2 sales and profit beat estimates; iPhone sales down 10%
Apple Inc. (NASDAQ: AAPL) on Thursday reported better-than-expected profit and revenue for the second quarter of 2024. There was a 10% decrease in iPhone sales. The gadget giant reported revenues
Shopify (SHOP) is all set to report Q1 2024 results. Here’s what to expect
Over the years, Shopify Inc. (NYSE: SHOP) has steadily expanded its footprint in the online retail market through constant innovation, like the recent launch of a mobile POS device for
eBay (EBAY): A look at how the ecommerce company fared in Q1 2024
Shares of eBay Inc. (NASDAQ: EBAY) were down over 2% on Thursday. The company reported its earnings results for the first quarter of 2024 a day ago, with revenue and